Biotech

All Articles

Arrowhead fires off period 3 records in rare metabolic disease in advance of market clash with Ionis

.Arrowhead Pharmaceuticals has presented its own hand before a possible showdown along with Ionis, p...

Pfizer, Valneva reveal lyme disease try successful for 2nd booster

.Pfizer as well as Valneva may have about two additional years to wait before they make the very fir...

Fierce Biotech Editor-in-Chief Ayla Ellison Speaks Shop with Michelle Benz on the Future of Biotech.

.Permit's study a conversation with Ayla Ellison, Strong Biotech Managing Editor as well as Michelle...

New records show how Bayer's asundexian stopped working to stop movements

.Bayer suspended the phase 3 test for its own aspect XIa inhibitor asundexian behind time in 2013 af...

Sanofi's tolebrutinib fails 2 of 3 late-stage MS tests

.Sanofi is still set on taking its own a number of sclerosis (MS) med tolebrutinib to the FDA, execs...

Galapagos' stockpile as fund reveals intent to form its own development

.Galapagos is happening under additional tension coming from clients. Having actually built a 9.9% s...

Cell- focused Sana scoops first CSO-- Chutes &amp Ladders

.Welcome to recently's Chutes &amp Ladders, our summary of notable leadership hirings, shootings as ...

Allist pays off Jacobio $21M, landing role in Mandarin KRAS race

.Shanghai Allist Pharmaceuticals has bought itself a starring character in China's KRAS market, payi...

ReNeuron leaving behind objective exchange after skipping fundraising objective

.ReNeuron has participated in the lengthy list of biotechs to leave Greater london's AIM securities ...

MBX declare IPO to take challenger to Ascendis into phase 3

.MBX Biosciences has actually added to the latest outbreak of IPO filings. The biotech, which filed ...